These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26275478)

  • 1. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions.
    Venkataraman A; Yusuff M; Liebeschuetz S; Riddell A; Prendergast AJ
    Vaccine; 2015 Oct; 33(41):5470-5474. PubMed ID: 26275478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital.
    Bolursaz MR; Lotfian F; Velayati AA
    Allergol Immunopathol (Madr); 2017; 45(4):356-361. PubMed ID: 28161281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacille Calmette-Guérin lymphadenitis.
    Goraya JS; Virdi VS
    Postgrad Med J; 2002 Jun; 78(920):327-9. PubMed ID: 12151684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Bacille Calmette-Guérin Lymphadenitis and Abscess in Immunocompetent Children: A Systematic Review.
    Villanueva P; Pittet LF; Curtis N
    Pediatr Infect Dis J; 2021 Nov; 40(11):1037-1045. PubMed ID: 34636800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
    Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
    Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and outcomes of Bacille Calmette-Guérin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization.
    Rermruay R; Rungmaitree S; Chatpornvorarux S; Brukesawan C; Wittawatmongkol O; Lapphra K; Phongsamart W; Kongstan N; Khumcha B; Chokephaibulkit K
    Vaccine; 2018 Jun; 36(28):4046-4053. PubMed ID: 29859799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
    Nazir Z; Qazi SH
    J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of surgical management of BCG vaccine-induced regional suppurative lymphadenitis in children: a 7 years' experience from one medical center.
    Liu C; Huang M; Liu F; Xu X; Feng W; Han G; Liu X; Zheng B; Geng L; Fu T
    BMC Infect Dis; 2021 Aug; 21(1):801. PubMed ID: 34380453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.
    Alrabiaah AA; Alsubaie SS; Bukhari EI; Gad A; Alzamel FA
    Ann Saudi Med; 2012; 32(1):4-8. PubMed ID: 22156633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
    Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
    PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity status in children with Bacille Calmette-Guerin adenitis. A prospective study in Tehran, Iran.
    Samileh N; Ahmad S; Farzaneh A; Shahnaz R; Lida F; Mohammad N
    Saudi Med J; 2006 Nov; 27(11):1719-24. PubMed ID: 17106549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination.
    Sataynarayana S; Mathur AD; Verma Y; Pradhan S; Bhandari MK
    J Assoc Physicians India; 2002 Jun; 50():788-91. PubMed ID: 12240843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
    Cerdá de Palou E; de Santy HP
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations into an outbreak of suppurative lymphadenitis with BCG vaccine SSI(®) in Singapore.
    Soh SB; Han PY; Tam KT; Yung CF; Liew WK; Tan NW; Chong CY; Thoon KC
    Vaccine; 2014 Oct; 32(44):5809-15. PubMed ID: 25173482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacille Calmette-Guérin adenitis: diagnostic and therapeutic guidelines].
    Constant C; Figueiredo A; Brito MJ
    Acta Med Port; 2011 Dec; 24 Suppl 2():263-8. PubMed ID: 22849911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral cephalexin in the treatment of BCG lymphadenitis.
    Ayazi P; Mahyar A; Taremiha A; Ghorani N; Esmailzadehha N
    Infez Med; 2014 Jun; 22(2):112-7. PubMed ID: 24955797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
    Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.